Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Looking for participantsNCT06349889
What this trial is testing

Adebrelimab and Chemoradiotherapy in High-risk LANPC

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT00376987
What this trial is testing

Zinc Supplements in Lowering Cadmium Levels in Smokers

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Wake Forest University Health Sciences 61
Testing effectiveness (Phase 2)Ended earlyNCT02062632
What this trial is testing

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Who this might be right for
Esophageal CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+11 more
Mayo Clinic 5
Large-scale testing (Phase 3)Looking for participantsNCT07327216
What this trial is testing

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Affiliated Hospital of Guangdong Medical University 180
Early research (Phase 1)Looking for participantsNCT04754321
What this trial is testing

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryLocally Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Ohio State University Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06234748
What this trial is testing

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Who this might be right for
Oropharynx CancerHPV-Related Carcinoma
University of Michigan Rogel Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT00004164
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT04446663
What this trial is testing

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
First People's Hospital of Foshan 50
Testing effectiveness (Phase 2)UnknownNCT00816816
What this trial is testing

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 64
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT00158652
What this trial is testing

Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC

Who this might be right for
Oral CancerOropharynx CancerHypopharynx Cancer+1 more
Groupe Oncologie Radiotherapie Tete et Cou 840
Testing effectiveness (Phase 2)UnknownNCT01612286
What this trial is testing

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 30
Not applicableUnknownNCT00173381
What this trial is testing

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Who this might be right for
Oral CancerLaryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Not applicableNot Yet RecruitingNCT07198802
What this trial is testing

Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 600
Testing effectiveness (Phase 2)UnknownNCT00004094
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01447056
What this trial is testing

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoproliferative Disorder+3 more
Baylor College of Medicine 37
Large-scale testing (Phase 3)Active Not RecruitingNCT04456322
What this trial is testing

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 381
Testing effectiveness (Phase 2)UnknownNCT02636231
What this trial is testing

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 96
Large-scale testing (Phase 3)Active Not RecruitingNCT07201337
What this trial is testing

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 700
Next Page